A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab

J Thorac Oncol. 2017 Jul;12(7):e96-e97. doi: 10.1016/j.jtho.2017.03.008.

Authors

Monica Khunger¹, Vamsidhar Velcheti²

Affiliations

¹ Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio.
² Department of Hematology and Oncology, Cleveland Clinic, Cleveland, Ohio. Electronic address: velchev@ccf.org.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antineoplastic Agents, Immunological / pharmacology
Antineoplastic Agents, Immunological / therapeutic use*
Carcinoma, Squamous Cell / diet therapy*
Carcinoma, Squamous Cell / pathology
Humans
Idiopathic Pulmonary Fibrosis / drug therapy*
Idiopathic Pulmonary Fibrosis / pathology
Lung Neoplasms / drug therapy*
Lung Neoplasms / pathology
Male
Nivolumab / pharmacology
Nivolumab / therapeutic use*

Substances

Antineoplastic Agents, Immunological
Nivolumab